Asia vs Indonesia: Proportion of the target population who received the final dose
Asia
14.0%
in 2024
Indonesia
79.0%
in 2024
Asia rank
27th
Indonesia rank
24th
Proportion of the target population who received the final dose over time
- Asia
- Indonesia
How they compare
Indonesia currently reports 79.0% against 14.0% in Asia, a difference of 65.0%.
That makes Indonesia's figure about 5.6 times Asia's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Indonesia ahead.
Asia ranks 27th and Indonesia ranks 24th of 34 groups.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Asia | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 2.7% | 0.7% | Indonesia |
| 2020s | 6.0% | 24.6% | 18.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Asia or Indonesia?
- Indonesia, at 79.0% against 14.0% in Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Asia and Indonesia?
- 65.0%, with Indonesia ahead.
- How many years of comparable data are there for Asia and Indonesia?
- 8 years are reported by both, from 2017 to 2024.
- How do Asia and Indonesia rank globally for proportion of the target population who received the final dose of?
- Asia ranks 27th and Indonesia ranks 24th of 34 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.